Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma

Affiliations

• ¹ Department of Pathology, Microbiology and Immunology, Division of Transfusion Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ² Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ³ Cancer and Blood Disorders Institute, Blood Bank and Transfusion Medicine, Johns Hopkins All Children's Hospital, St Petersburg, Florida, USA.
• ⁴ Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁵ American Red Cross, Biomedical Services Headquarters, Washington, DC, USA.
• ⁶ Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ⁷ Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
• ⁸ Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.